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INFECTIOUS DISEASE

A Case Report of Bullous Subconjunctival
Hemorrhage in Adenoviral Conjunctivitis
Sean Haynie and Jesse Johnson, MD

INTRODUCTION
Subconjunctival hemorrhage is a benign and self-limiting
condition that often occurs without any obvious trauma
to the eye. Most cases do not cause pain or changes in
vision, and thus no active management is required. We
present a case of subconjunctival hemorrhage that
resulted in the formation of bullae and caused significant
ophthalmic morbidity in a patient on therapeutic anticoagulation with adenoviral conjunctivitis.

CASE
A 78-year-old female with a past medical history of optic
neuropathy and atrial fibrillation on warfarin presented
with two weeks of progressive bilateral eye redness,
swelling, pain, and blurry vision. Initially, the patient was
experiencing symptoms only in her right eye, and the
contralateral eye became involved throughout the course
of her illness. Examination was remarkable for bilateral
bullous subconjunctival hemorrhage and trace edema of
her eyelids with tenderness to palpation (Figure 1).
Tonometry, computed tomography scan of the orbits,
and fluorescein stain were all unrevealing. A viral
respiratory pathogen panel was positive for adenovirus,
and INR appropriately elevated to 2.13 on admission.
Other laboratory tests were within normal limits. She was
treated with carboxymethylcellulose sodium 0.5%
ophthalmic solution and erythromycin 0.5% ophthalmic
ointment 5mg/g three times daily, which significantly
improved both her pain and blurry vision. The patient was
discharged and scheduled to follow up with oculoplastics
and ophthalmology.
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Figure 1. Bilateral subconjunctival hemorrhage with edematous eyelids
and watery discharge.

DISCUSSION
The conjunctiva is a thin transparent membrane that
covers the sclera as well as the inner surface of the
eyelid.1 Inflammation of this membrane is known as
conjunctivitis.1 Viral conjunctivitis is typically caused by
adenovirus and is the most common overall cause of
infectious conjunctivitis.2 The virus itself is spread through
direct contact with an infected individual or their
secretions as well as contaminated objects or surfaces.3
Most often, patients will present with injection, watery or
mucoserous discharge, and a burning or gritty sensation
affecting one of their eyes.4 However, it is common for
the other eye to become involved within the first 24-48
hours.4 This condition is self-limiting, with symptoms
worsening over the first three to five days, followed by a
gradual recovery over two to three weeks.4 While antiviral
agents are not indicated in the treatment of viral conjunctivitis, patients may benefit from the use of topical antihistamines, decongestants, or lubrication by either antibiotic
or nonantibiotic ointments.1 The patient in this case did
not demonstrate the classic presentation of viral conjunctivitis, specifically with regard to her prolonged period of
worsening symptoms, and bullous subconjunctival
hemorrhage. Subconjunctival hemorrhage is a common
condition and refers to bleeding into the compartment
located between the conjunctiva and the episclera.5
There are many know risk factors associated with subconjunctival hemorrhage, including acute conjunctivitis,
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trauma, contact lens use, systemic vascular disease, and
anticoagulation therapy.5,6 Alternatively, bullous subconjunctival hemorrhage, marked by the presence of
conjunctival bullae, is an exceedingly rare condition that
is generally limited to cases of ocular trauma with scleral
rupture. 5 To date, there appears to be no cases of
non-traumatic bullous subconjunctival hemorrhage, such
as that seen in our patient. Without other known risk
factors, it is possible that her warfarin use, in the setting
of adenoviral conjunctivitis, contributed to this unique
presentation.
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